Brain Diseases  >>  Activase (alteplase)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
NCT00412867: Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

Completed
4
58
Japan
Alteplase, Tissue Plasminogen Activator, GRTPA, ACTIVACIN
Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co., Ltd.
Stroke
06/08
06/08

Download Options